In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $15.12 in the prior trading day, Constellium SE (NYSE: CSTM) closed at $14.94, down -1.19%. In other words, the price has decreased by -$1.19 from its previous closing price. On the day, 1.1 million shares were traded. CSTM stock price reached its highest trading level at $15.37 during the session, while it also had its lowest trading level at $14.77.
Ratios:
Our goal is to gain a better understanding of CSTM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.53 and its Current Ratio is at 1.23. In the meantime, Its Debt-to-Equity ratio is 2.76 whereas as Long-Term Debt/Eq ratio is at 2.66.
On October 24, 2024, Deutsche Bank Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $22 to $12.
On January 16, 2024, UBS started tracking the stock assigning a Buy rating and target price of $27.UBS initiated its Buy rating on January 16, 2024, with a $27 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CSTM now has a Market Capitalization of 2084712960 and an Enterprise Value of 4120712960. As of this moment, Constellium’s Price-to-Earnings (P/E) ratio for their current fiscal year is 77.69, and their Forward P/E ratio for the next fiscal year is 8.52. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 2.67. Its current Enterprise Value per Revenue stands at 0.542 whereas that against EBITDA is 7.293.
Stock Price History:
The Beta on a monthly basis for CSTM is 1.72, which has changed by -0.100000024 over the last 52 weeks, in comparison to a change of 0.15535986 over the same period for the S&P500. Over the past 52 weeks, CSTM has reached a high of $17.03, while it has fallen to a 52-week low of $7.32. The 50-Day Moving Average of the stock is 4.68%, while the 200-Day Moving Average is calculated to be 25.29%.
Shares Statistics:
The stock has traded on average 1.37M shares per day over the past 3-months and 1146820 shares per day over the last 10 days, according to various share statistics. A total of 139.54M shares are outstanding, with a floating share count of 125.37M. Insiders hold about 10.15% of the company’s shares, while institutions hold 82.11% stake in the company. Shares short for CSTM as of 1756425600 were 3684384 with a Short Ratio of 2.69, compared to 1753920000 on 3803124. Therefore, it implies a Short% of Shares Outstanding of 3684384 and a Short% of Float of 3.61.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 2.0 analysts currently analyzing and rating the stock of Constellium SE (CSTM).The consensus estimate for the next quarter is $0.24, with high estimates of $0.24 and low estimates of $0.24.
Analysts are recommending an EPS of between $1.08 and $0.97 for the fiscal current year, implying an average EPS of $1.03. EPS for the following year is $1.57, with 2.0 analysts recommending between $1.64 and $1.49.
Revenue Estimates
3 analysts predict $1.81B in revenue for. The current quarter. It ranges from a high estimate of $1.96B to a low estimate of $1.74B. As of. The current estimate, Constellium SE’s year-ago sales were $1.64BFor the next quarter, 3 analysts are estimating revenue of $1.69B. There is a high estimate of $1.78B for the next quarter, whereas the lowest estimate is $1.6B.
A total of 3 analysts have provided revenue estimates for CSTM’s current fiscal year. The highest revenue estimate was $7.28B, while the lowest revenue estimate was $6.88B, resulting in an average revenue estimate of $7.03B. In the same quarter a year ago, actual revenue was $7.03BBased on 3 analysts’ estimates, the company’s revenue will be $7.42B in the next fiscal year. The high estimate is $7.95B and the low estimate is $7.07B.
